These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 3334965

  • 1. Different antitumor mechanisms of interferon-alpha in the treatment of hairy cell leukemia and renal cell cancer.
    Porzsolt F, Digel W, Jacobsen H, Mittnacht S, Kirchner H, Heimpel H.
    Cancer; 1988 Jan 15; 61(2):288-93. PubMed ID: 3334965
    [Abstract] [Full Text] [Related]

  • 2. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B, Hokland M, Justesen J, Hasselbalch H, Ellegaard J, Hokland P.
    Eur J Haematol; 1989 Jan 15; 42(1):50-9. PubMed ID: 2914594
    [Abstract] [Full Text] [Related]

  • 3. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D, Billard C, Sigaux F, Thang MN, Falcoff E.
    J Biol Regul Homeost Agents; 1987 Jan 15; 1(3):147-53. PubMed ID: 2459906
    [Abstract] [Full Text] [Related]

  • 4. Deficient IFN alpha production in hairy cell leukemia.
    Porzsolt F, Janik R, Heil G, Brudler O, Raghavachar A, Scholz S, Papendick U, Heimpel H.
    Blut; 1986 Mar 15; 52(3):185-90. PubMed ID: 3006840
    [Abstract] [Full Text] [Related]

  • 5. Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.
    Capnist G, Federico M, Chisesi T, Resegotti L, Pagnucco G, Castoldi GL, Lamparelli T, Frassoldati A, Guarnaccia C, Leoni P.
    Leuk Res; 1991 Mar 15; 15(6):419-26. PubMed ID: 1861528
    [Abstract] [Full Text] [Related]

  • 6. Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
    Triozzi PL, Avery KA, Grever MR, Kraut EH.
    J Interferon Res; 1990 Oct 15; 10(5):535-40. PubMed ID: 2273300
    [Abstract] [Full Text] [Related]

  • 7. Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.
    Gastl G, Aulitzky W, Leiter E, Flener R, Huber C.
    Blut; 1986 May 15; 52(5):273-9. PubMed ID: 3635416
    [Abstract] [Full Text] [Related]

  • 8. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V, Fehr J, Sauter C, Ottino J.
    Cancer Treat Rev; 1985 Dec 15; 12 Suppl B():33-7. PubMed ID: 3833328
    [Abstract] [Full Text] [Related]

  • 9. Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients.
    Billard C, Ferbus D, Sigaux F, Castaigne S, Degos L, Flandrin G, Falcoff E.
    Leuk Res; 1988 Dec 15; 12(1):11-8. PubMed ID: 2965776
    [Abstract] [Full Text] [Related]

  • 10. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H, Zwingers T, Boedewadt S, Bross K, Dörken B, Gamm H, Ho AD, Parwaresch RM, Schmitz N, Papendick U.
    Onkologie; 1987 Feb 15; 10(1):5-10. PubMed ID: 3295625
    [Abstract] [Full Text] [Related]

  • 11. Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma.
    Genot E, Billard C, Sigaux F, Mathiot C, Degos L, Falcoff E, Kolb JP.
    Leukemia; 1987 Aug 15; 1(8):590-6. PubMed ID: 2444836
    [Abstract] [Full Text] [Related]

  • 12. Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.
    Lepe-Zuniga JL, Quesada JR, Baron S, Reuben J, Gutterman JU.
    Hematol Pathol; 1987 Aug 15; 1(3):157-65. PubMed ID: 3150846
    [Abstract] [Full Text] [Related]

  • 13. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G, Werter M, De Pauw B, Nerl C, Aulitzky W, von Lüttichau I, Tilg H, Thaler J, Lang A, Abbrederis K.
    Leukemia; 1989 Jun 15; 3(6):453-60. PubMed ID: 2725061
    [Abstract] [Full Text] [Related]

  • 14. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
    Shehata M, Schwarzmeier JD, Nguyen ST, Hilgarth M, Berger R, Hubmann R, Kickmaier S, Decker T.
    Cancer Res; 2000 Oct 01; 60(19):5420-6. PubMed ID: 11034083
    [Abstract] [Full Text] [Related]

  • 15. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
    Preble OT, Rook AH, Steis R, Silverman RH, Krause D, Quinnan GV, Masur H, Jacob J, Longo D, Gelmann EP.
    J Infect Dis; 1985 Sep 01; 152(3):457-65. PubMed ID: 2993441
    [Abstract] [Full Text] [Related]

  • 16. Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.
    Steis RG, Smith JW, Urba WJ, Venzon DJ, Longo DL, Barney R, Evans LM, Itri LM, Ewel CH.
    Blood; 1991 Feb 15; 77(4):792-8. PubMed ID: 1704264
    [Abstract] [Full Text] [Related]

  • 17. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Ho AD, Thaler J, Mandelli F, Lauria F, Zittoun R, Willemze R, McVie G, Marmont AM, Prümmer O, Stryckmans P.
    J Clin Oncol; 1989 Oct 15; 7(10):1533-8. PubMed ID: 2789273
    [Abstract] [Full Text] [Related]

  • 18. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
    Damasio EE, Frassoldati A.
    Leuk Lymphoma; 1994 Oct 15; 14 Suppl 1():95-8. PubMed ID: 7820061
    [Abstract] [Full Text] [Related]

  • 19. Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.
    Porzsolt F, Messerer D, Hautmann R, Gottwald A, Sparwasser H, Stockamp K, Aulitzky W, Moormann JG, Schumacher K, Rasche H.
    J Cancer Res Clin Oncol; 1988 Oct 15; 114(1):95-100. PubMed ID: 2965154
    [Abstract] [Full Text] [Related]

  • 20. Evidence for an association between hairy cell leukemia and renal cell and colorectal carcinoma.
    Nielsen B, Braide I, Hasselbalch H.
    Cancer; 1992 Oct 15; 70(8):2087-90. PubMed ID: 1394039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.